WOOJUNG BIO Financials
| 215380 Stock | KRW 1,740 27.00 1.53% |
WOOJUNG |
Understanding current and past WOOJUNG BIO Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of WOOJUNG BIO's financial statements are interrelated, with each one affecting the others. For example, an increase in WOOJUNG BIO's assets may result in an increase in income on the income statement.
Please note, the presentation of WOOJUNG BIO's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, WOOJUNG BIO's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of WOOJUNG BIO's management manipulating its earnings.
WOOJUNG BIO Stock Summary
WOOJUNG BIO competes with AptaBio Therapeutics, and Genolution. WOOJUNG BIO, Inc. provides research and laboratory services in Korea. WOOJUNG BIO, Inc. was founded in 1989 and is based in Suwon, South Korea. WOOJUNG BIO is traded on Korean Securities Dealers Automated Quotations in South Korea.| Instrument | Korea Stock View All |
| Exchange | KOSDAQ |
| ISIN | KR7215380007 |
| Business Address | Next Generation Convergence |
| Sector | Healthcare |
| Industry | Biotechnology & Medical Research |
| Benchmark | Dow Jones Industrial |
| Website | www.woojungbsc.co.kr |
| Phone | 82 3 1888 9369 |
| Currency | KRW - South Korean Won |
You should never invest in WOOJUNG BIO without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of WOOJUNG Stock, because this is throwing your money away. Analyzing the key information contained in WOOJUNG BIO's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
WOOJUNG BIO Key Financial Ratios
WOOJUNG BIO's financial ratios allow both analysts and investors to convert raw data from WOOJUNG BIO's financial statements into concise, actionable information that can be used to evaluate the performance of WOOJUNG BIO over time and compare it to other companies across industries.| Return On Equity | -24.14 | |||
| Return On Asset | -0.0566 | |||
| Number Of Employees | 10 | |||
| Beta | 0.98 | |||
| Z Score | 1.2 |
WOOJUNG Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining WOOJUNG BIO's current stock value. Our valuation model uses many indicators to compare WOOJUNG BIO value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across WOOJUNG BIO competition to find correlations between indicators driving WOOJUNG BIO's intrinsic value. More Info.WOOJUNG BIO is rated third in return on equity category among its peers. It is number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value WOOJUNG BIO by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for WOOJUNG BIO's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.WOOJUNG BIO Systematic Risk
WOOJUNG BIO's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. WOOJUNG BIO volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on WOOJUNG BIO correlated with the market. If Beta is less than 0 WOOJUNG BIO generally moves in the opposite direction as compared to the market. If WOOJUNG BIO Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one WOOJUNG BIO is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of WOOJUNG BIO is generally in the same direction as the market. If Beta > 1 WOOJUNG BIO moves generally in the same direction as, but more than the movement of the benchmark.
WOOJUNG BIO November 26, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of WOOJUNG BIO help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of WOOJUNG BIO. We use our internally-developed statistical techniques to arrive at the intrinsic value of WOOJUNG BIO based on widely used predictive technical indicators. In general, we focus on analyzing WOOJUNG Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build WOOJUNG BIO's daily price indicators and compare them against related drivers.
| Downside Deviation | 5.26 | |||
| Information Ratio | (0.01) | |||
| Maximum Drawdown | 43.28 | |||
| Value At Risk | (9.14) | |||
| Potential Upside | 29.88 |
Complementary Tools for WOOJUNG Stock analysis
When running WOOJUNG BIO's price analysis, check to measure WOOJUNG BIO's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy WOOJUNG BIO is operating at the current time. Most of WOOJUNG BIO's value examination focuses on studying past and present price action to predict the probability of WOOJUNG BIO's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move WOOJUNG BIO's price. Additionally, you may evaluate how the addition of WOOJUNG BIO to your portfolios can decrease your overall portfolio volatility.
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Stocks Directory Find actively traded stocks across global markets | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |